Tumor necrosis factor-α disruption of brain endothelial cell barrier is mediated through matrix metalloproteinase-9 Discussion

被引:0
|
作者
Mammen, Josh
Wiggins-Dohlvik, Katie
机构
来源
AMERICAN JOURNAL OF SURGERY | 2014年 / 208卷 / 06期
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:960 / 960
页数:1
相关论文
共 50 条
  • [21] Blood-Brain Barrier Disruption in Humans Is Independently Associated With Increased Matrix Metalloproteinase-9
    Barr, Taura L.
    Latour, Lawrence L.
    Lee, Kyung-Yul
    Schaewe, Timothy J.
    Luby, Marie
    Chang, George S.
    El-Zammar, Ziad
    Alam, Shaista
    Hallenbeck, John M.
    Kidwell, Chelsea S.
    Warach, Steven
    STROKE, 2010, 41 (03) : E123 - E128
  • [22] Cyclooxygenase-2 Is Involved in the Up-Regulation of Matrix Metalloproteinase-9 in Cholangiocarcinoma Induced by Tumor Necrosis Factor-α
    Itatsu, Keita
    Sasaki, Motoko
    Yamaguchi, Junpei
    Ohira, Shusaku
    Ishikawa, Akira
    Ikeda, Hiroko
    Sato, Yasunori
    Harada, Kenichi
    Zen, Yoh
    Sato, Hiroshi
    Ohta, Tetsuo
    Nagino, Masato
    Nimura, Yuji
    Nakanuma, Yasuni
    AMERICAN JOURNAL OF PATHOLOGY, 2009, 174 (03): : 829 - 841
  • [23] Tumor necrosis factor-α and not interleukin-1α is the dominant inducer of matrix metalloproteinase-9 synthesis in human corneal cells
    Bevans-Nelson, SE
    Lausch, RN
    Oakes, JE
    EXPERIMENTAL EYE RESEARCH, 2001, 73 (03) : 403 - 407
  • [24] Effect of proinflammatory cytokines, tumor necrosis factor-α and interferon-γ on epithelial barrier function and matrix metalloproteinase-9 in Madin Darby canine kidney cells
    Leone, Amanda K.
    Chun, Jennifer A.
    Koehler, Christopher L.
    Caranto, Jonathan
    King, Jonathan M.
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2007, 19 (1-4) : 99 - 112
  • [25] Disruption of Nrf2 Enhances the Upregulation of Nuclear Factor-kappaB Activity, Tumor Necrosis Factor-α, and Matrix Metalloproteinase-9 after Spinal Cord Injury in Mice
    Mao, Lei
    Wang, Handong
    Qiao, Liang
    Wang, Xiaoliang
    MEDIATORS OF INFLAMMATION, 2010, 2010
  • [26] Increased Serum Matrix Metalloproteinase-9 in Neuromyelitis Optica; Implication of Disruption of Blood-Brain Barrier
    Hosokawa, Takafumi
    Nakajima, Hideto
    Doi, Yoshimitsu
    Sugino, Masakazu
    Kimura, Fumiharu
    Hanafusa, Toshiaki
    Takahashi, Toshiyuki
    NEUROLOGY, 2010, 74 (09) : A167 - A167
  • [27] Increased serum matrix metalloproteinase-9 in neuromyelitis optica: Implication of disruption of blood-brain barrier
    Hosokawa, Takafumi
    Nakajima, Hideto
    Doi, Yoshimitsu
    Sugino, Masakazu
    Kimura, Fumiharu
    Hanafusa, Toshiaki
    Takahashi, Toshiyuki
    JOURNAL OF NEUROIMMUNOLOGY, 2011, 236 (1-2) : 81 - 86
  • [28] MATRIX METALLOPROTEINASE-9 IN TUMOR-CELL INVASION
    FRENCH, DL
    RAMOSDESIMONE, N
    ROZINSKI, K
    NUOVO, GJ
    INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC POTENTIAL, 1994, 732 : 324 - 334
  • [29] Naringin inhibits matrix metalloproteinase-9 expression and AKT phosphorylation in tumor necrosis factor-α-induced vascular smooth muscle cells
    Lee, Eo-Jin
    Kim, Dong-Il
    Kim, Wun-Jae
    Moon, Sung-Kwon
    MOLECULAR NUTRITION & FOOD RESEARCH, 2009, 53 (12) : 1582 - 1591
  • [30] Interferons inhibit tumor necrosis factor-α-mediated matrix metalloproteinase-9 activation via interferon regulatory factor-1 binding competition with NF-κB
    Sancéau, J
    Boyd, DD
    Seiki, M
    Bauvois, B
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (38) : 35766 - 35775